Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1488)
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
32,359
Price
$91.85
Total Value
$2.97M
Shares Held After
3,712,404
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
62,897
Price
$90.48
Total Value
$5.69M
Shares Held After
3,744,763
% of Holdings
1.7%
Kura Oncology, Inc. (KURA)
Leoni Mollie — Chief Medical Officer
Shares
84,929
Price
$9.82
Total Value
$834.28K
Shares Held After
182,345
% of Holdings
31.8%
NovaBridge Biosciences (NBP)
Dennis Phillip Andrew — Chief Medical Officer
Shares
8,494
Price
$0.66
Total Value
$5.61K
Shares Held After
157,941
% of Holdings
5.1%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
46,901
Price
$20.07
Total Value
$941.37K
Shares Held After
4,112,218
% of Holdings
1.1%
VERACYTE, INC. (VCYT)
EASTHAM KARIN — Director
Shares
529
Price
$53.55
Total Value
$28.33K
Shares Held After
15,097
% of Holdings
3.4%
VERACYTE, INC. (VCYT)
EASTHAM KARIN — Director
Shares
3,200
Price
$52.78
Total Value
$168.91K
Shares Held After
15,626
% of Holdings
17.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
660
Price
$548.90
Total Value
$362.28K
Shares Held After
18,876
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
115
Price
$547.81
Total Value
$63.00K
Shares Held After
19,536
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
265
Price
$547.37
Total Value
$145.05K
Shares Held After
19,651
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$545.19
Total Value
$21.81K
Shares Held After
19,916
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$543.53
Total Value
$21.74K
Shares Held After
19,956
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
192
Price
$541.88
Total Value
$104.04K
Shares Held After
19,996
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
865
Price
$541.06
Total Value
$468.02K
Shares Held After
20,188
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,978
Price
$540.22
Total Value
$1.61M
Shares Held After
21,053
% of Holdings
12.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,035
Price
$539.42
Total Value
$1.10M
Shares Held After
24,031
% of Holdings
7.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,440
Price
$538.31
Total Value
$775.16K
Shares Held After
26,066
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
600
Price
$537.24
Total Value
$322.34K
Shares Held After
27,506
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
210
Price
$536.27
Total Value
$112.62K
Shares Held After
28,106
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
160
Price
$534.48
Total Value
$85.52K
Shares Held After
28,316
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$533.59
Total Value
$213.43K
Shares Held After
28,476
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$552.72
Total Value
$88.44K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$548.84
Total Value
$263.45K
Shares Held After
40,673
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$547.51
Total Value
$175.20K
Shares Held After
41,153
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$545.19
Total Value
$21.81K
Shares Held After
41,473
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$544.01
Total Value
$21.76K
Shares Held After
41,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
613
Price
$541.49
Total Value
$331.94K
Shares Held After
41,553
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,022
Price
$540.52
Total Value
$1.09M
Shares Held After
42,166
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,793
Price
$539.62
Total Value
$1.51M
Shares Held After
44,188
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,399
Price
$538.59
Total Value
$753.49K
Shares Held After
46,981
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
828
Price
$537.52
Total Value
$445.07K
Shares Held After
48,380
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
245
Price
$536.59
Total Value
$131.47K
Shares Held After
49,208
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$535.01
Total Value
$42.80K
Shares Held After
49,453
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$533.79
Total Value
$256.22K
Shares Held After
49,533
% of Holdings
1.0%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Bumpus Namandje — Director
Shares
3,963
Price
$3.18
Total Value
$12.60K
Shares Held After
127,632
% of Holdings
3.0%
Xencor Inc (XNCR)
Feigal Ellen — Director
Shares
6,843
Price
$13.06
Total Value
$89.37K
Shares Held After
12,340
% of Holdings
35.7%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
3,000
Price
$6.35
Total Value
$19.05K
Shares Held After
700,000
% of Holdings
0.4%
Nkarta, Inc. (NKTX)
HASTINGS PAUL J — Director
Shares
1,776
Price
$2.71
Total Value
$4.81K
Shares Held After
390,247
% of Holdings
0.5%
Vericel Corp (VCEL)
Halpin Michael — Chief Operating Officer
Shares
10,000
Price
$40.24
Total Value
$402.40K
Shares Held After
16,248
% of Holdings
38.1%
Vericel Corp (VCEL)
Flynn Sean C. — Chief Legal Officer
Shares
15,000
Price
$40.21
Total Value
$603.15K
Shares Held After
1,647
% of Holdings
90.1%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
81,898
Price
$5.99
Total Value
$490.49K
Shares Held After
378,195
% of Holdings
17.8%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
2,634
Price
$35.39
Total Value
$93.22K
Shares Held After
180,597
% of Holdings
1.4%
Cardiff Oncology, Inc. (CRDF)
PACE GARY W — Director
Shares
30,000
Price
$1.22
Total Value
$36.60K
Shares Held After
1,356,376
% of Holdings
2.2%
Cardiff Oncology, Inc. (CRDF)
Mohindru Mani — Director
Shares
24,703
Price
$1.21
Total Value
$29.89K
Shares Held After
24,703
% of Holdings
100.0%
IMMUCELL CORP /DE/ (ICCC)
te Boekhorst Paul Francis Olivier — Director
Shares
8,000
Price
$9.49
Total Value
$75.96K
Shares Held After
17,785
% of Holdings
45.0%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
37,015
Price
$50.00
Total Value
$1.85M
Shares Held After
521,795
% of Holdings
6.6%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
4,656
Price
$50.00
Total Value
$232.80K
Shares Held After
558,810
% of Holdings
0.8%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
800
Price
$0.96
Total Value
$768.00
Shares Held After
300,566
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
96
Price
$147.11
Total Value
$14.12K
Shares Held After
15,000
% of Holdings
0.6%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
1,199
Price
$146.24
Total Value
$175.35K
Shares Held After
15,096
% of Holdings
7.4%
Showing 601–650 of 1488 transactions (page 13 of 30)